Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AGfiledCriticalCiba Geigy AG
Publication of ES259314A1publicationCriticalpatent/ES259314A1/en
Process for the preparation of new quinonic derivatives, characterized in that the 2,5-dihalogen-3-6-bis-acylamino-p-benzoquinomes, in which the acyl residue is that of a cycloaliphatic carbonic acid, are reacted with ethylenic imines. (Machine-translation by Google Translate, not legally binding)
ES0259314A1959-07-171960-06-30Procedure for the obtaining of new quinonic derivatives (Machine-translation by Google Translate, not legally binding)
ExpiredES259314A1
(en)
Procedure for manufacturing and obtaining compounds and derivatives of benzotidyacine-1,1-dioxides (chlorotidates) (Machine-translation by Google Translate, not legally binding)